XBiotech Yönetim

Yönetim kriter kontrolleri 2/4

XBiotech CEO'su John Simard, Mar2005 tarihinde atandı, in görev süresi 19.67 yıldır. in toplam yıllık tazminatı $ 5.56M olup, şirket hissesi ve opsiyonları dahil olmak üzere 19.2% maaş ve 80.8% ikramiyelerden oluşmaktadır. şirketin hisselerinin 12.54% ine doğrudan sahiptir ve bu hisseler $ 25.31M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 7 yıl ve 7.6 yıldır.

Anahtar bilgiler

John Simard

İcra Kurulu Başkanı

US$5.6m

Toplam tazminat

CEO maaş yüzdesi19.2%
CEO görev süresi19.7yrs
CEO sahipliği12.5%
Yönetim ortalama görev süresi7yrs
Yönetim Kurulu ortalama görev süresi7.6yrs

Son yönetim güncellemeleri

Recent updates

Is XBiotech (NASDAQ:XBIT) Weighed On By Its Debt Load?

Aug 30
Is XBiotech (NASDAQ:XBIT) Weighed On By Its Debt Load?

XBiotech: Several Shots On Goal In Big Target Market Indications

May 24

Is XBiotech (NASDAQ:XBIT) Using Debt In A Risky Way?

May 13
Is XBiotech (NASDAQ:XBIT) Using Debt In A Risky Way?

We're Not Very Worried About XBiotech's (NASDAQ:XBIT) Cash Burn Rate

Feb 09
We're Not Very Worried About XBiotech's (NASDAQ:XBIT) Cash Burn Rate

We're Hopeful That XBiotech (NASDAQ:XBIT) Will Use Its Cash Wisely

Oct 25
We're Hopeful That XBiotech (NASDAQ:XBIT) Will Use Its Cash Wisely

We Think Some Shareholders May Hesitate To Increase XBiotech Inc.'s (NASDAQ:XBIT) CEO Compensation

Jun 16
We Think Some Shareholders May Hesitate To Increase XBiotech Inc.'s (NASDAQ:XBIT) CEO Compensation

XBiotech (NASDAQ:XBIT) Is In A Good Position To Deliver On Growth Plans

May 11
XBiotech (NASDAQ:XBIT) Is In A Good Position To Deliver On Growth Plans

Read This Before Buying XBiotech Inc. (NASDAQ:XBIT) Shares

Mar 18
Read This Before Buying XBiotech Inc. (NASDAQ:XBIT) Shares

Here's Why We Don't Think XBiotech's (NASDAQ:XBIT) Statutory Earnings Reflect Its Underlying Earnings Potential

Jan 08
Here's Why We Don't Think XBiotech's (NASDAQ:XBIT) Statutory Earnings Reflect Its Underlying Earnings Potential

XBiotech's influenza-COVID-19 therapeutic cocktail shows effective anti-virus activity

Nov 19

CEO Tazminat Analizi

John Simard'un ücretlendirmesi XBiotech'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$33m

Jun 30 2024n/an/a

-US$35m

Mar 31 2024n/an/a

-US$31m

Dec 31 2023US$6mUS$1m

-US$25m

Sep 30 2023n/an/a

-US$23m

Jun 30 2023n/an/a

-US$28m

Mar 31 2023n/an/a

-US$31m

Dec 31 2022US$5mUS$881k

-US$33m

Sep 30 2022n/an/a

-US$36m

Jun 30 2022n/an/a

-US$27m

Mar 31 2022n/an/a

-US$20m

Dec 31 2021US$8mUS$777k

-US$17m

Sep 30 2021n/an/a

-US$13m

Jun 30 2021n/an/a

-US$12m

Mar 31 2021n/an/a

-US$14m

Dec 31 2020US$3mUS$684k

-US$11m

Sep 30 2020n/an/a

US$677m

Jun 30 2020n/an/a

US$673m

Mar 31 2020n/an/a

US$674m

Dec 31 2019US$11mUS$591k

US$669m

Sep 30 2019n/an/a

-US$24m

Jun 30 2019n/an/a

-US$23m

Mar 31 2019n/an/a

-US$23m

Dec 31 2018US$1mUS$585k

-US$21m

Sep 30 2018n/an/a

-US$22m

Jun 30 2018n/an/a

-US$23m

Mar 31 2018n/an/a

-US$27m

Dec 31 2017US$702kUS$566k

-US$33m

Tazminat ve Piyasa: John 'nin toplam tazminatı ($USD 5.56M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 1.46M ).

Tazminat ve Kazançlar: John şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.


CEO

John Simard (62 yo)

19.7yrs

Görev süresi

US$5,556,481

Tazminat

Mr. John Simard is the Founder of XBiotech, Inc. and serves as its Chairman and has been its Chief Executive Officer and President since March 2005. Mr. Simard serves as the Chairman, Chief Executive Offic...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
John Simard
Founder19.7yrsUS$5.56m12.54%
$ 25.3m
Angela Hu
Director of Finance1.8yrsUS$279.29k0.084%
$ 168.8k
Sushma Shivaswamy
Chief Scientific Officer7yrsUS$720.50k0%
$ 0

7.0yrs

Ortalama Görev Süresi

46yo

Ortalama Yaş

Deneyimli Yönetim: XBIT 'un yönetim ekibi deneyimli ve deneyimlidir ( 7 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
John Simard
Founder19.7yrsUS$5.56m12.54%
$ 25.3m
W. McKenzie
Independent Director15.8yrsUS$190.94k8.65%
$ 17.5m
Donald MacAdam
Independent Director6.7yrsUS$187.94k0.033%
$ 66.2k
Peter Libby
Member of Scientific Advisory Board & Independent Director6.2yrsUS$163.94k0.082%
$ 165.5k
Alice Gottlieb
Member of Scientific Advisory Board6.2yrsVeri yokVeri yok
Alexander Knuth
Member of Scientific Advisory Board7.6yrsVeri yokVeri yok
Razelle Kurzrock
Member of Scientific Advisory Board7.6yrsVeri yokVeri yok
Andrew Hendifar
Member of Scientific Advisory Board7.6yrsVeri yokVeri yok
Jan-Paul Waldin
Lead Independent Director6.8yrsUS$196.94k0.66%
$ 1.3m
Evangelos Giamarellos-Bourboulis
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Mark Rupp
Member of Scientific Advisory Boardno dataVeri yokVeri yok

7.6yrs

Ortalama Görev Süresi

75yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: XBIT 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7.6 yıldır).